Lovastatin Tablet
Product Images NDC 51655-686

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 51655-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 686 52 Master Bottle Label Approval Rev A 04 21)

Label (51655 686 52 Master Bottle Label Approval   Rev A 04 21)
Lovastatin is a tablet used for medical purposes, each containing 10mg of the active ingredient. The tablets come in a bottle of 30 and require a prescription. They should be kept in their original container, protected from light and stored at a controlled room temperature of 20°-25°C (68-77°F). Lovastatin is repackaged by the Northwind Pharmaceuticals in Indianapolis and sourced from Carlsbad Technology in lot number 0000000000. The GTIN number is 0035165686522 and the S/N is 000000000000000. The expiration date is 00/00/0000.*
FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

Figure 1 (Lov00 0004 03)
The text describes a figure (Figure 1) related to the proportion of participants without an acute major coronary event over a follow-up period of 1 to 4 years. It appears to be related to a primary endpoint of a study, but no further information is available.*
FDA Label Image

Table Vii (Lov00 0005 04)

Table Vii (Lov00 0005 04)
The given text provides a table of drug interactions that are associated with increased risk of myopathy/rhabdomyolysis. The table lists several prescribing recommendations for various drugs such as strong CYP3A4 inhibitors, HIV protease inhibitors, Gemfibrozil, Cyclosporine, Danazol, Difiazem, Dronedarone, and grapefruit juice. The recommended doses and usage for each drug are also mentioned in the table.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.